Biomarker-Based Approaches for Assessing Alcohol Use Disorders

Area of Science:

• Clinical Biochemistry
• Public Health
• Toxicology

Background:

• Alcohol use disorders are a major global health concern, frequently underdiagnosed.
• Hazardous drinking contributes significantly to morbidity and mortality worldwide.
• Current diagnostic methods may not fully capture the impact of alcohol abuse on health.

Purpose of the Study:

• To highlight the importance of systematic biomarker use for detecting alcohol abuse.
• To outline specific biomarkers for assessing recent and chronic alcohol consumption.
• To emphasize the role of biomarkers in evaluating alcohol-related health consequences.

Main Methods:

• Utilizing questionnaires for recent alcohol intake.
• Measuring ethanol and its specific metabolites (e.g., ethyl glucuronide).
• Assessing chronic heavy drinking with carbohydrate-deficient transferrin.
• Screening for liver dysfunction using liver enzymes.
• Evaluating immune activation and fibrogenesis markers for tissue damage.

Main Results:

• Biomarkers like ethyl glucuronide and carbohydrate-deficient transferrin aid in detecting alcohol consumption patterns.
• Liver enzyme activity indicates ethanol-induced liver dysfunction and associated co-morbidities.
• Immune and fibrogenesis markers help assess the severity of alcohol-induced tissue damage.
• Biomarker levels are influenced by lifestyle factors and demographics, requiring careful interpretation.

Conclusions:

• Systematic biomarker analysis is crucial for improving the diagnosis of alcohol use disorders.
• A comprehensive biomarker approach can identify alcohol's role in various health problems.
• Further research is needed to establish standardized reference intervals for biomarkers across different populations.